Recently RAD $ 1.54 has come off it's low and Flu season sales are very robust. You will need a big winner to make of the time and loses KNDI has delivered. Plus Rad can help you with your KNDI head ache. confirmation is in todays Forbes article and Wag hitting 52 week highs last week on strong sales. My other picks Siri and NOK are still beating KNDI.
I'm looking for a sustainable trend RAD $ 1.48 is the way. Just off multi yr. loses and lows in stock price then beating the street and raising guidance. The flu shots are being sold out and this trend has just started and other support products are having the same demands. RAD is a gold mind and is working on refinancing a private equity group or insurance group or hospital group would do well to get RAD. RAD is a great way to play on the new insurance rules. Rad valuations Price to sales .05 are just to compelling and a very big part to health care in the future front line demand. RAD is price at 1/10 it's peers WAG CVS they won't double in stock price like RAD or triple. Check the charts, check the analyst upgrades, look at the increased volume and the money flow.